In focus · trending topic

Targeted Lung Denervation

2 stories · following the connections

Nuvaira Announces 1st Patient Treated in RELIEF-1 Study Evaluating New Approach for Asthma Treatment

By Nasdaq OMXMar 27, 2018, 12:01 PM UTC

Nuvaira Announces Enrollment Completion in First Sham-Controlled Clinical Trial of Targeted Lung Denervation for COPD

By Nasdaq OMXJun 27, 2017, 1:00 PM UTC